title: NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma.
authors.forename: Christian
authors.initials: C
authors.lastname: Griffiths
authors.forename: Nicola
authors.initials: N
authors.lastname: Hay
authors.forename: Frances
authors.initials: F
authors.lastname: Sutcliffe
authors.forename: Andrew
authors.initials: A
authors.lastname: Stevens
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib